RAPT THERAPEUTICS
RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary discovery and development engine, the company is developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases. In its first four years since inception, RAPT has discov... ered and advanced two unique drug candidates, each targeting C-C motif chemokine receptor 4. The companyโs lead oncology drug candidate, FLX475, reached the clinic in just two and a half years with its lead inflammation drug candidate, RPT193, also in the clinic. The company is also pursuing a range of targets, including general control nonderepressible 2 and hematopoietic progenitor kinase 1, that are in the discovery stage of development.
RAPT THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2015-03-04
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.rapt.com
Total Employee:
101+
Status:
Active
Contact:
+116504899000
Email Addresses:
[email protected]
Total Funding:
369.7 M USD
Technology used in webpage:
SPF SSL By Default Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS Microsoft GoDaddy SSL Smart App Banner
Similar Organizations
Actym Therapeutics, Inc.
Actym Therapeutics is a privately-held biotech focused on the discovery and development of novel immuno-oncology therapies to treat cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Blueprint Medicines
Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Cyclica
Cyclica is the partner of choice for data-driven drug discovery.
Effector Therapeutics
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
GlycoBioChem
GlycoBioChem is focused on discovery and development of novel small-molecules for the purposes of research and treatment of human diseases.
Insitro
Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.
MiNDERA Corporation
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
QureBio
QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals.
Rgenta Therapeutics
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.
ShouTi
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Westlake Therapeutics
The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.
XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation
Zavante Therapeutics
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Redmile Group
Redmile Group investment in Post-IPO Equity - Rapt Therapeutics
Solasta Ventures
Solasta Ventures investment in Post-IPO Equity - Rapt Therapeutics
Topspin Partners
Topspin Partners investment in Series C - Rapt Therapeutics
The Column Group
The Column Group investment in Series C - Rapt Therapeutics
Regents of the University of California
Regents of the University of California investment in Series C - Rapt Therapeutics
Kleiner Perkins
Kleiner Perkins investment in Series C - Rapt Therapeutics
Topspin Partners
Topspin Partners investment in Series C - Rapt Therapeutics
Kleiner Perkins
Kleiner Perkins investment in Series C - Rapt Therapeutics
Celgene
Celgene investment in Series C - Rapt Therapeutics
GV
GV investment in Series C - Rapt Therapeutics
Official Site Inspections
http://www.rapt.com Semrush global rank: 4.76 M Semrush visits lastest month: 1.95 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago